Kiniksa Pharmaceuticals International Free Cash Flow Analysis

Kiniksa Pharmaceuticals International Plc (KNSA)

46.75 +0.91 (+1.99%) USD | NASDAQ | Mar 26, 11:12

View Free Cash Flow for KNSA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Free Cash Flow Chart

Start Trial

View Historical Data

Start Trial

View Free Cash Flow Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Free Cash Flow Benchmarks

Start Trial

Marker Therapeutics, Inc.	-12.01M
NovoCure Ltd.	-75.68M
LivaNova Plc	173.29M
Aurinia Pharmaceuticals, Inc.	135.69M
Alterola Biotech, Inc.	--

Cash from Operations (Quarterly)	53.89M
Cash from Investing (Quarterly)	-70.81M
Cash from Financing (Quarterly)	7.658M
Free Cash Flow Per Share (Quarterly)	0.653
Free Cash Flow to Equity (Quarterly)	53.48M
Free Cash Flow to Firm (Quarterly)	53.26M
Free Cash Flow Yield	3.70%